business

Johnson & Johnson Announces Departure of Ashley McEvoy, Tim Schmid Named Executive Vice President, Worldwide Chairman of MedTech

October 24, 2023

Johnson & Johnson announced today that Ashley McEvoy, Executive Vice President, Worldwide Chairman of MedTech, informed the company on October 20, 2023, that she is stepping down from her position to pursue other opportunities. Tim Schmid has been appointed Executive Vice President, Worldwide Chairman of MedTech, joining the Company’s Executive Committee. […]

Enovis to Acquire LimaCorporate S.p.A.

October 2, 2023

Enovis, an innovation-driven, medical technology growth company, today announced a definitive agreement to acquire LimaCorporate, a privately held global orthopedic leader focused on restoring motion through an innovative portfolio of implant solutions. […]

Bryan Hanson Named CEO of 3M’s Health Care Business Group

August 22, 2023

3M (NYSE: MMM) today announced the appointment of Bryan C. Hanson as Chief Executive Officer of the independent health care company when it is spun off from 3M. […]

Globus Medical and NuVasive to Combine in All-Stock Transaction to Create Innovative Global Musculoskeletal Company Focused on Patient Care

February 9, 2023

Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and NUVASIVE (NASDAQ: NUVA), the leader in spine technology innovation, today announced they have entered into a definitive agreement to combine in an all-stock transaction. […]

Medical device industry poised to withstand an economic slowdown, experts say

August 26, 2022

(MedTech Dive) – Medical device companies are poised to weather an economic slowdown even as they continue to face hurdles linked to the pandemic such as persistent supply chain woes and staff shortages, analysts say. […]

J&J, other orthopedics companies faced unequal pandemic recovery in second quarter

August 17, 2022

(MEDTECH DIVE) – Orthopedics companies such as Johnson & Johnson benefited from rising procedure volumes in the second quarter, even as foreign-exchange rates, material costs and supply chain issues continued to weigh on their earnings. […]